ReviewInternational journal of molecular sciences2021

Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.

Yannick Verhoeven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.